Symbol Lookup

Tuesday December 01, 2015 6:01 AM ET. Data delayed 15 minutes.
0.00 (0.00%)
Open/Prev Close
Day Range
52-Week Range
Vol/Avg Daily Vol
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
A.C. Simmonds And Sons Acquires Position In Cardiogenics Holdings Inc.
8:55AM ET on Tuesday Nov 17, 2015 by Accesswire

TORONTO, ON / ACCESSWIRE / November 17, 2015 / A.C. Simmonds and Sons Inc., (OTCPK:ACSX) announced today it has acquired, through a transfer of shares and assumption of debt, an equity position in CardioGenics Holdings Inc. A.C. Simmonds and So...

CardioGenics Enters Into Asset Purchase Agreement to Acquire All Assets of Ontario-Based Plasticap
1:46PM ET on Wednesday Nov 04, 2015 by Marketwire

CardioGenics Holdings Inc. (OTCQB: CGNH), developer of the ultra-sensitive QL Care(TM) analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics ("IVD") testing market, announced today that it, and its new...

Company Information

CardioGenics Holdings Inc. is engaged in development of products targeting the immunoassay segment of the point-of-care in vitro diagnostic (IVD) testing market. The Company is engaged in development of technology and products, which include The QL Care Analyzer (QLCA), Cardiovascular Tests and Paramagnetic beads. The QLCA is a point-of-care (POC) immunoassay analyzer. The Company has developed four immunoassay tests designed to identify cardiac markers in the blood at the time of a heart attack. These tests include Troponin I (TnI), Plasminogen Activator Inhibitor Type-1 (PAI-1), Heart Failure Risk Stratification (HFRS) and Heart Failure Genomics Risk (HFGR). Clinical and research laboratories use paramagnetic particles as a solid surface in heterogeneous immunoassay tests. Paramagnetic (magnetic) beads are the solid phase employed during immunoassays tests in these laboratories.


Headquarters6865 SW 18th St Ste B13
BOCA RATON, FL, United States 33433-7057


Acting Independent Chairman of the BoardJ.Neil Tabatznik
Chief Executive Officer, DirectorYahia Gawad
Chief Financial OfficerJames Essex
Corporate Secretary, DirectorLinda Sterling
Independent DirectorKarim Murabet

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$3.9MBeta1.35
Revenue (TTM)$0.00EPS$-0.04
Shares Out.80.6MBook Value$-0.02
CardioGenics Holdings Inc does not pay a dividend.P/E--
Price/Sales (TTM)--
P/Cash Flow (TTM)--
Operating Margin--

*GAAP = prior to non-GAAP analyst adjusted earnings.


Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample